Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02041052
Other study ID # 2011/1262-31/3
Secondary ID 2011/1262-31/3
Status Terminated
Phase Phase 2
First received December 10, 2013
Last updated January 4, 2017
Start date January 2013
Est. completion date December 2014

Study information

Verified date January 2017
Source Karolinska University Hospital
Contact n/a
Is FDA regulated No
Health authority Sweden: Swedish Research Council
Study type Interventional

Clinical Trial Summary

A small gastric remnant after whipple resection improves gastric emptying and therefore prevents the development of delayed gastric emptying.


Description:

Every patient submitted to a whipple resection and at the same time present with characteristics suggestive of minimal risk for leakage from the pancreaticojejunostomy will be included in the study. At the time of reconstruction the patient will be randomized to either conventional size of the stomach or to a subtotal gastrectomy containing a small upper gastric pouch only.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

All patients undergoing whipple procedure with preoperative assignment as low risk for leakage from the pancreaticojejunal anastomosis.

- Signed informed consent.

Exclusion Criteria:

- High and intermediate risk pancreaticojejunal anastomosis. Unwillingness to participate.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Subtotal gastrectomy as an adjunct to traditional whipple procedure.
Subtotal gastrectomy as an adjunct to traditional whipple procedure.
Conventional whipple procedure
All patients undergoing whipple procedure without risk for pancreaticojejunal anastomosis leakage.

Locations

Country Name City State
Sweden Karolinska University Hospital Gastrocentrum Stockholm

Sponsors (4)

Lead Sponsor Collaborator
Karolinska University Hospital Afshin Noorani, John Blomberg, Ralf Segersvärd

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative delayed gastric emptying During the postoperative phase the patient will be followed daily with assessment of symptoms suggestive of delayed gastric emptying. Postoperative recovery period in days (on an average <20 days) No
Secondary Quality of life Quality of life measured by use of scientifically validated instruments. during three first postoperative months No
Secondary Postoperative hospital stay Time in days from the operation to discharge from hospital. In hospital stay in days (on an average <20 days) No
Secondary Total Gastric emptying as measured by the paracetamol test Paracetamol orally ingested together with chocolate biscuits whereafter peripheral venous blood concentrations of paracetamol are determined. Blood samples taken at baseline and every 15 minutes after paracetamol ingestion during the first hour and then every 30 minutes for an hour. three months postoperatively No